Bemfola

Bemfola is a fertility medication containing follitropin alfa, used to stimulate ovulation. This subcutaneous injection is manufactured by Gedeon Richter Plc. and is suitable for assisted reproductive techniques.

Bemfola is primarily used in fertility treatments to stimulate the ovaries to produce eggs. It is often part of assisted reproductive techniques like in vitro fertilization (IVF). The active ingredient, follitropin alfa, mimics natural follicle-stimulating hormone (FSH) to support ovulation.

Common effects of Bemfola may include mild injection site reactions, such as redness or swelling. Some users might experience headaches, abdominal discomfort, or mood changes. These effects are generally mild and temporary.

Bemfola should be used under medical supervision. It is important to follow the prescribed dosage and administration instructions. Users should be monitored for ovarian hyperstimulation syndrome (OHSS), a potential risk associated with fertility treatments.

Bemfola may interact with other medications, including those that affect hormone levels. It is advisable to consult a healthcare provider before using Bemfola with other medications. Alcohol and certain supplements may also influence its effectiveness.